These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 18639519

  • 21. Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey.
    Boles J, West M, Montgomery V, Tammariello R, Pitt ML, Gibbs P, Smith L, LeClaire RD.
    Toxicon; 2006 Jun 15; 47(8):877-84. PubMed ID: 16730042
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action.
    Atassi MZ.
    Toxicon; 2009 Oct 15; 54(5):600-13. PubMed ID: 19285100
    [Abstract] [Full Text] [Related]

  • 26. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
    Dolimbek GS, Dolimbek BZ, Aoki KR, Atassi MZ.
    Immunol Invest; 2005 Oct 15; 34(2):119-42. PubMed ID: 15921155
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW.
    Clin Vaccine Immunol; 2008 Dec 15; 15(12):1819-23. PubMed ID: 18845829
    [Abstract] [Full Text] [Related]

  • 30. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
    Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR.
    Mol Immunol; 2008 Sep 20; 45(15):3878-88. PubMed ID: 18676021
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER.
    J Cell Biol; 2003 Sep 29; 162(7):1293-303. PubMed ID: 14504267
    [Abstract] [Full Text] [Related]

  • 37. Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.
    Berntsson RP, Peng L, Svensson LM, Dong M, Stenmark P.
    Structure; 2013 Sep 03; 21(9):1602-11. PubMed ID: 23932591
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R.
    Mol Immunol; 2009 Jun 03; 46(10):2107-15. PubMed ID: 19356802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.